✦ LIBER ✦

Combined Modality Therapy Including Surgery for Stage III Small-Cell Lung Cancer on the Basis of the Sensitivity Assay In Vitro

✍ Scribed by Shunsuke Kobayashi; Shinichiro Okada; Toru Hasumi; Nobuyuki Sato; Shigefumi Fujimura

Book ID: 113012651
Publisher: Springer
Year: 2000
Tongue: English
Weight: 488 KB
Volume: 30
Category: Article
ISSN: 1436-2813
DOI: 10.1007/pl00010060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Candidates for surgery in the combined m

Candidates for surgery in the combined modality therapy of stage III non-small cell lung cancer

✍ Kathy S. Albain 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Combined modality therapy in the managem

Combined modality therapy in the management of stage III non-small cell lung cancer

✍ Curran, Walter J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Targeted therapies for stage III non-sma

Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting

✍ Vokes, Everett E.; Choy, Hak 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Computed tomography in the staging of sm

Computed tomography in the staging of small cell lung cancer: Implications for combined modality therapy

✍ John D. Norlund; Roger W. Byhardt; W.Dennis Foley; George F. Unger; James D. Cox 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 512 KB

Computed tomography in the staging of sm

Computed tomography in the staging of small cell lung cancer: Implications for combined modality therapy

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 99 KB

The value of combined-modality therapy i

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l